Randomised trials of molecular testing for pneumonia
Stephen Poole1, Tristan W Clark2
1Department of Infection, University Hospital Southampton National Health Service Foundation Trust, Southampton SO16 6YD, UK.
The Lancet. Microbe
|December 1, 2024
Summary
No abstract available in PubMed .
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
168
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
168
01:28Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299